Oral Solid Dosage Trends

Tuesday, December 24, 2019

Ashland

American Pharmaceutical asked our readers several questions regarding the technologies and processes they use, and the issues they face, when developing oral solid dosage (OSD) products. The results of our survey are below and provide an insight into the challenges manufacturers face when bringing new OSD products to market.

What technologies are you most likely to use when formulating oral solids?
What is the area of greatest challenge when formulating oral solids?
Which solid dispersion manufacturing process is your company using?
Which polymers do you use for solid dispersions?
How many of your late stage development projects are slated to be produced by continuous manufacturing technology?
How many of your products in clinical trials are based on solid dispersion technology?
  • <<
  • >>

  • Ashland’s Calvert City, Kentucky Facility Receives EXCiPACT Certification

    Ashland has announced that its Calvert City, Kentucky, facility has earned EXCiPACTTM certification for Good Manufacturing Practice (GMP). Its scope covers the manufacturing, testing and packaging of polyvinylpyrrolidone (PVP) and polyvinylpolypyrrolidone (PVPP) used as pharmaceutical excipients.

Join the Discussion